"El Hospital Español es una organización prestadora de servicios de salud."

During the past decade, Hospital Español de Mexico conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Español de Mexico" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Español de Mexico" are "Diffuse Large B-Cell Lymphoma (DLBCL)" (1 trials), "Follicular NHL Grade 3b" (1 trials), "Gastric pH Control" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Hospital Español de Mexico" in a lesser frequency.

Most popular intervention types in "Hospital Español de Mexico" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Magnesium Pantoprazole 20 mg" (1 trials), "Magnesium Pantoprazole 40 mg" (1 trials), "Placebo" (1 trials), "Rituximab" (1 trials) and "rituximab [MabThera/Rituxan]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Español de Mexico" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Español de Mexico". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Español de Mexico, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Español de Mexico, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".